Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incomplete lupus progression biomarker study
NL-OMON45013Recruiting
- Sponsor
- Nederlandse Federatie van Universitair Medische Centra
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydroxychloroquine in systemic lupus erythematosus (SLE) and lupus erythematosus (SLE) (2 arms), sponsored by Nederlandse Federatie van Universitair Medische Centra. Started Mar 2016; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
systemic lupus erythematosus (SLE)lupus erythematosus (SLE)
Beyond the preview
Go deeper on NL-OMON45013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45013.